Few characteristics of dengue's fever epidemiology in Brazil by Teixeira, Maria Glória
Rev. Inst. Med. Trop. Sao Paulo
54(Suppl. 18):S1-S4, October, 2012
Presented at the I International Symposium on Dengue of the School of Medicine University of São Paulo on October 6, 2011.
(1) Public Health Institute, Federal University of Bahia. 
Correspondence to: Rua Pancararé 221. Condomínio Aldeia Jaguaribe. Piatã, 41650-640 Salvador, Bahia, Brazil. Phone: +55.71.3283-7412. E-mail: magloria@ufba.br
FEW CHARACTERISTICS OF DENGUE’S FEVER EPIDEMIOLOGY IN BRAZIL
Maria Glória TEIXEIRA(1)
Brazil, in the 21st century, began to occupy the first position in the 
world ranking of Dengue’s Fever (DF) reported cases, with an incidence 
ranging from 63.2 (2004) to 429.9 (2010) per 100,000 inhabitants (Fig. 
1), and is among the ten most at risk countries for this disease. When it 
comes to efforts, from the government and society, aiming to control this 
disease, the epidemiological situation has been worsening. Currently, in 
the field of infectious diseases, dengue fever is the main health problem 
in the country.
In fact, besides the increased incidence that has been noticed, 
dengue fever expresses in the form of explosive epidemics, affecting 
urban centers at small and large-scale, causing fear and unsafety to the 
population, particularly by the risk of Dengue´s Hemorrhagic Fever 
(DHF) occurrence. In these situations, the demand for medical care goes 
beyond the capacity of network services, the quality of care to affected 
patients is much less than desired, the distrust of the population in 
leaders, managers and health services is established, which makes even 
harder the management of such periods of crisis which succeeds every 
summer in our country. Thus, a picture of extreme fragility of the Public 
Health is established.
This scenario is not only due to some conjuncture circumstances 
because, in addition to the magnitude of DF incidence and the rates of 
hospitalization in the last 10 years, the increased severity of clinical 
manifestations of the disease is evidenced. Thus, if in the 1990s the 
maximum figure for this indicator was 4.0 admissions by dengue fever 
per 100,000 inhabitants (1998), in the period from 2000 to 2010 this 
figure has increased reaching 49.7/100,000 inhabitants (2010), a trend 
that alone reveals the rise of severe dengue fever cases in Brazil (Fig. 2). 
In turn, the number of cases diagnosed as DHF, according to the strict 
WHO criteria published in 19977, also became more frequent. Therefore, 
in the period from 1990 to 2000 the proportion of DHF cases in relation to 
the total reported cases of DF, which was 0.06%, reached 0.46% in 2010, 
corresponding to more than seven times the cases observed in the 1990s. 
Another epidemiological feature of dengue fever that, from 2007, 
has also undergone significant changes, is regarding the distribution by 
age group. While up to 2006, both DF and DHF affected predominantly 
adults, in 2007 a shift in the occurrence of DF and DHF was observed 
to earlier ages2,4,5,6. 
This worsening is due to the conjunction of several factors, among 
which stands out the time (more than 25 years) of intense circulation 
of different serotypes of dengue virus in the country (Fig. 1). This 
situation has established high levels of specific serotype antibodies in 
the population, a fact that raises the risk of occurrence of severe cases 
due to the phenomenon of immune amplification3. On the other hand, 
the magnitude of this risk is not the same for all ages, as it depends on 
the immunity levels established in each age group for each serotype and 
specifically the serotype that is more intensive circulating at each time. 
Fig. 1 - Annual distribution of dengue incidence per 100,000 population and number of municipalities infested by Aedes aegypti. Brazil, 1986-2010.
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This dynamics has been determining different patterns of occurrence of 
severe dengue cases in each urban area, as can be seen in the Brazilian 
state capitals, provided in Figure 4. Thus, it is verified that currently, 
Fig. 2 - Changes in Incidence and Rates of Hospitalization by Dengue. Brazil, 1986 - 2010 .
Fig. 3 - Hospitalization for Dengue Hemorrhagic in the SUS network of hospitals, by age group.
DF and DHF in Brazil has been occurring in all age groups. However, 
children are paying a higher cost to this disease due to the increased risk 
of being affected by the severe forms2,4,5,6. The introduction of DENV4 
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Fig. 4 -  Morbidade Hospitalar do SUS - por local de residência - Brasil
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and re-emergence of serotype DENV1 in 20104 has pointed to possible 
new severe epidemics in the next transmission seasons of dengue virus.
Fortunately, it seems that, on the near horizon there is the perspective 
of new vaccines available to combat dengue virus. However, at least 
in the upcoming years, there will be no availability for this type of 
immunogen for the entire population. Moreover, the current vaccine 
candidate is proposed to be used in three-dose regimen at intervals of 
six months. These limitations impose initiatives to be taken towards 
the improvement of medical care to reduce the lethality of the disease 
as well as improvement and development of new technologies and 
ways to combat Aedes aegypti. In turn, because of the particularities of 
epidemiological expression of dengue in time, space and person requires 
that vaccination strategies to be adopted in Brazil consider immunity 
per age group, history and dengue trend at each site, individual risk 
factors, in addition to joint actions for vector combat in all aspects 
(social participation, chemical control, sanitation, etc). Therefore, the 
use of a vaccine against dengue fever will require the efforts of the 
“epidemiological intelligence” in the country in view of the search for 
impact on the occurrence of dengue from these interventions. 
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